[Accessed on 11 June 2026] Orforglipron pill shows promise in maintaining weight loss after injections (2026)
The following are contraindications for this treatment: Family history of thyroid cancer Allergy to any active ingredient Certain medicationsdiscuss any medications you are on during your consultation Patient with Multiple Endocrine Neoplastic Syndrome Type 2 (MENS 2) If you have any of the following, inform your consultant about it/them: Gastroparesis Pancreatitis Visual problems Kidney issues Pregnancy and breastfeeding Hypoglycemia Adults are typically considered for medical weight management with semaglutide-class therapy when their BMI is 30, or 27 with weight-related comorbidities (Type 2 diabetes, hypertension, dyslipidemia, sleep apnea, established cardiovascular disease)
Substances Detected: Marijuana Cocaine Opiates Amphetamines Methamphetamines Alcohol Urine tests are cost-effective and best for recent use, blood tests are precise but invasive, hair tests offer long-term detection, and saliva tests are quick for immediate results
17 (5:30 to 7 p.m.): Public comment only
Enzymology of microsomal glutathione S-transferase
